Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
Clinical trial NCT00506779 · TERMINATED
Trial details
- NCT number
- NCT00506779
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-29
- Primary completion
- 2015-04-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.